Bio-Rad Laboratories (BIO) Gross Margin (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Gross Margin for 18 consecutive years, with 53.12% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Margin rose 13.0% year-over-year to 53.12% in Q2 2026; TTM through Jun 2026 was 51.9%, a 92.0% decrease from a year earlier, with the FY2025 full-year figure at 51.87%, down 186.0% from the prior year.
• Gross Margin was 53.12% for Q2 2026 at Bio-Rad Laboratories, up from 52.25% in the prior quarter.
• Over five years, Gross Margin peaked at 57.51% in Q1 2022 and troughed at 49.8% in Q4 2025.
• A 5-year average of 53.63% and a median of 53.29% in 2023 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin surged 240 bps in 2022 and plunged 396 bps in 2023, its largest moves.
• Over 5 years, Gross Margin stood at 54.37% in 2022, then decreased by 1 bps to 53.77% in 2023, then slipped by 5 bps to 51.24% in 2024, then decreased by 3 bps to 49.8% in 2025, then gained by 7 bps to 53.12% in 2026.
• The last three Gross Margin figures came in at 53.12% (Q2 2026), 52.25% (Q1 2026), and 49.8% (Q4 2025), per Business Quant data.